Incidence of malignant mesothelioma of the pleura in Québec and Canada from 1984 to 2007, and projections from 2008 to 2032

American Journal of Industrial Medicine

Volumn 58, Issue 5, 2015, Pages 473-482

  Krupoves, Alfreda ^a   Camus, Michel ^b   De Guire, Louise ^a,b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Age cohort analysis; Asbestos; Mesothelioma; Projections; Time trends

Indexed keywords

ASBESTOS; CARCINOGEN;

ADULT; ADVERSE EFFECTS; AGED; CANADA; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; FORECASTING; HUMAN; INCIDENCE; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL DISEASES; PLEURAL NEOPLASMS; POISSON DISTRIBUTION; QUEBEC; REGISTER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASBESTOS; CANADA; CARCINOGENS; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; FORECASTING; HUMANS; INCIDENCE; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL DISEASES; PLEURAL NEOPLASMS; POISSON DISTRIBUTION; QUEBEC; REGISTRIES;

EID: 84926421170     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.22442     Document Type: Article

References (46)

1. Adib G. 2013. Projet Amiante-Industries 2012: Bilan. Montréal: Institut national de santé publique du Québec.
2. Beaudry C, Begin D, Moldovanu M, Gérin M. 2008. Surveillance de l'exposition à l'amiante dans les métiers de la construction. Montréal: Université de Montréal, Faculté de médecine, Département de santé environnementale de santé au travail.
3. Beaudry R, Gilles Lagacé G, Juteau L, Rochette M. 1976. Rapport final. Comité d'étude sur la salubrité dans l'industrie de l'amiante. Québec: Éditeur officiel du Québec.
4. Bianchi C, Bianchi T. 2007. Malignant mesothelioma: Global incidence and relationship with asbestos. Ind Health 45(3):379-387.
5. Breslow NE, Day NE. 1987. The design and analysis of cohort studies. Lyon: International Agency for Research on Cancer.
6. Bureau of Labor Statistics USDoL. 1962. Labor force and employment trends in Canada, 1950-60. Month Labor Rev 85(6):668-672.
7. Camus M, Siemiatycki J, Meek B. 1998. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med 338(22):1565-1571.
8. Canadian Cancer Registry. 2014. (http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3207) (Accessed April 20, 2014).
9. Carella R, Deleonardi G, D'Errico A, Salerno A, Egarter-Vigl E, Seebacher C, Donazzan G, Grigioni WF. 2001. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: A study with logistic regression analysis. Am J Surg Pathol 25(1):43-50.
10. Clayton D, Schifflers E. 1987. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 6(4):449-467.
11. Clements M, Berry G, Shi J, Ware S, Yates D, Johnson A. 2007. Projected mesothelioma incidence in men in New South Wales. Occup Environ Med 64(11):747-752.
12. Cree M, Lalji M, Jiang B, Carriere KC, Beach J, Kamruzzaman A. 2009. Explaining Alberta's rising mesothelioma rates. Chronic Dis Can 29(4):144-152.
13. De Guire L, Camus M, Case B, Langlois A, Laplante O, Lebel G, Lévesque B. 2004. The epidemiology of asbestos-related diseases in Québec. Montréal: Institut national de santé publique du Québec.
14. De Guire L, Lajoie P. 2004. Asbestos fibres in indoor and outdoor air and the epidemiology of asbestos-related diseases in Quebec: Summary and recommendations of the reports. Montréal: Institut national de santé publique du Québec.
15. Dubé-Linteau A, Beaudry C, De Guire L, Adib G. 2011. Asbestos: Current knowledge on the exposure and diseases of workers and the general population in Québec from 2003 to 2009. Montréal: Institut national de santé publique du Québec.
16. Éditeur officiel du Québec. 2013. Regulation to amend the Regulation respecting occupational health and safety and safety and the Safety Code for the construction industry. Gazette officielle du Québec.
17. Estève J, Benhamou E, Raymond L. 1994. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ 4(128):1-302.
18. Gibbs GW, Lachance M. 1972. Dust exposure in the chrysotile asbestos mines and mills of Quebec. Arch Environ Health 24(3):189-197.
19. Government of Québec. 2013. Public Health Act, CQLR c S-2.2. (http://canlii.ca/t/521b1) (Accessed October 10, 2014).
20. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. 2005. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 92(3):587-593.
21. Ilg AG, Bignon J, Valleron AJ. 1998. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med 55(11):760-765.
22. Kjaergaard J, Andersson M. 2000. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health 26(2):112-117.
23. Labreche F, Case BW, Ostiguy G, Chalaoui J, Camus M, Siemiatycki J. 2012. Pleural mesothelioma surveillance: validity of cases from a tumour registry. Can Respir J 19(2):103-107.
24. Lebel G, Gingras S. 2007. Descriptive epidemiology of the principal asbestos-related diseases in Québec, 1981-2004. Montréal: Institut national de santé publique du Québec.
25. Lebel G, Gingras S, De Guire L. 2009. Jumelage des cas de mésothéliome et d'amiantose reconnus comme maladies professionnelles pulmonaires aux nouveaux cas de cancer et aux hospitalisations avec amiantose. Montréal: Institut national de santé publique du Québec.
26. Leigh J, Driscoll T. 2003. Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health 9(3):206-217.
27. Magnani C, Dalmasso P, Biggeri A, Ivaldi C, Mirabelli D, Terracini B. 2001. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: A case-control study in Casale Monferrato, Italy. Environ Health Perspect 109(9):915-919.
28. Marrett LD, Ellison LF, Dryer D. 2008. Canadian cancer statistics at a glance: Mesothelioma. CMAJ 178(6):677-678.
29. Martel L, Caron-Malenfant É, Dion P. 2010. Population projections for Canada, provinces and territories, with detailed electronic tables, 2009-2036 (2009-2061 for Canada). Ottawa: Statistics Canada, Demography Division.
30. McCullagh P, Nelder JA. 1989. Generalized linear models. London: Chapman and Hall.
31. Momoli F, Karyakina N, Dennis J, Farhat N, Krewski D. 2009. Chrysotile asbestos exposures in Canada. Ottawa: Risk Sciences International.
32. Nishikawa K, Takahashi K, Karjalainen A, Wen CP, Furuya S, Hoshuyama T, Todoroki M, Kiyomoto Y, Wilson D, Higashi T, et al. 2008. Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: A global assessment. Environ Health Perspect 116(12):1675-1680.
33. Olsen NJ, Franklin PJ, Reid A, de Klerk NH, Threlfall TJ, Shilkin K, Musk B. 2011. Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation. Med J Aust 195(5):271-274.
34. Peto J, Decarli A, LaVecchia C, Levi F, Negri E. 1999. The European mesothelioma epidemic. Br J Cancer 79(3-4):666-672.
35. Peto J, Hodgson JT, Matthews FE, Jones JR. 1995. Continuing increase in mesothelioma mortality in Britain. Lancet 345(8949):535-539.
36. Price B. 1997. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 145(3):211-218.
37. Price B, Ware A. 2004. Mesothelioma trends in the United States: An update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 159(2):107-112.
38. Price B, Ware A. 2009. Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005. Crit Rev Toxicol 39(7):576-588.
39. Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. 2009. Occupational, domestic and environmental mesothelioma risks in the British population: A case-control study. Br J Cancer 100(7):1175-1183.
40. Reid A, Heyworth J, de Klerk NH, Musk B. 2008. Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia. Int J Cancer 122(10):2337-2344.
41. Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J. 1994. Malignant mesothelioma: Attributable risk of asbestos exposure. Occup Environ Med 51(12):804-811.
42. Statistics Canada. 2013. Life Tables, Canada, Provinces, Territories, 2009 to 2011. (http://www5. statcan.gc.ca/access_acces/alternative_alternatif.action?l=eng&loc=/pub/84-537-x/84-537-x2013005-eng.pdf.) (Accessed February 12, 2014).
43. Tonnel AB, Goldberg M, Hemon D, Bignon J, Billon-Galland MA, Brochard P, Brugere J, Cochet C, Jaurand MC, Laforest JC, et al. 1997. Effets sur la santé des principaux types d'exposition à l'amiante, rapport établi à la demande de la Direction des relations du travail et de la Direction générale de la santé. Paris: Éd. INSERM.
44. U.S. Geological Survey. 2011. Mineral commodity summaries 2011. USG. (http://minerals.usgs.gov/minerals/pubs/mcs/2011/mcs2011.pdf.) (Accessed December 12, 2013).
45. Virta RL. 2005. Mineral Commodity Profiles - Asbestos: Geological Survey Circular 1255-KK. vv. (http://pubs.usgs.gov/circ/2005/1255/kk/Circ_1255KK.pdf.) (Accessed October 10, 2013).
46. Weill H, Hughes JM, Churg AM. 2004. Changing trends in US mesothelioma incidence. Occup Environ Med 61(5):438-441.